Advertisement

Validity of the Modified Charlson Comorbidity Index as Predictor of Short-term Outcome in Older Stroke Patients

      The modified Charlson Comorbidity Index (MCCI) has been proposed as a tool for adjusting the outcomes of stroke for comorbidity, but its validity in such a context has been evaluated in only a few studies and needs to be further explored, especially in elderly patients. We aimed to retrospectively assess the validity of the MCCI as a predictor of the short-term outcomes in a cohort of 297 patients with first-ever ischemic stroke, older than 60 years, and managed according to a clinical pathway. The poor outcome (PO) at 1 month, defined as a modified Rankin Scale score of 3-6, was the primary end point. Furthermore, a new comorbidity index has been developed, specific to our cohort, according to the same statistical approach used for the original CCI. The MCCI showed a positive association with PO (odds ratio [OR] 1.62; 95% confidence interval [CI] .98-2.68) and mortality (hazard ratio [HR] 1.85; 95% CI .94-3.61), not statistically significant and totally dependent on its association with the severity of neurologic impairment at onset. The new comorbidity index showed, as expected, a significant association with the PO and mortality with higher point estimates of OR (2.74; 95% CI 1.64-4.59) and HR (2.73; 95% CI 1.51-4.94), but this association was also dependent on stroke severity and premorbid disability. Our results do not support the validity of the MCCI as a predictor of the short-term outcomes in elderly stroke patients nor could we develop a more valid index from the available data. This suggests the need for development of disease- and age-specific indexes, possibly according to a prospective design. In any case, initial stroke severity, a strong predictor of outcome, is associated with the degree of comorbidity.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Liu M.
        • Domen K.
        • Chino N.
        Comorbidity measures for stroke outcome research: a preliminary study.
        Arch Phys Med Rehabil. 1997; 78: 166-167
        • Goldstein L.B.
        • Samsa G.P.
        • Matchar D.B.
        • et al.
        Charlson Index comorbidity adjustment for ischemic stroke outcome studies.
        Stroke. 2004; 35: 1941-1945
        • Fischer U.
        • Arnold M.
        • Nedeltchev K.
        • et al.
        Impact of comorbidity on ischemic stroke outcome.
        Acta Neurol Scand. 2006; 113: 108-113
        • Bushnell C.D.
        • Lee J.
        • Duncan P.W.
        • et al.
        Impact of comorbidities on ischemic stroke outcomes in women.
        Stroke. 2008; 39: 2138-2140
        • Tessier A.
        • Finch L.
        • Daskalopoulou S.S.
        • et al.
        Validation of the Charlson Comorbidity Index for predicting functional outcome of stroke.
        Arch Phys Med Rehabil. 2008; 89: 1276-1283
        • Bar B.
        • Hemphill III, C.
        Charlson Comorbidity Index adjustment in intracerebral hemorrhage.
        Stroke. 2011; 42: 2944-2946
        • De Groot V.
        • Beckerman H.
        • Lamkhorst G.J.
        • et al.
        How to measure comorbidity: a critical review of available methods.
        J Clin Epidemiol. 2003; 56: 221-229
        • Charlson M.E.
        • Pompei P.
        • Ales K.L.
        • et al.
        A new method of classifying prognostic comorbidity longitudinal studies: development and validation.
        J Chronic Dis. 1987; 5: 371-383
        • Every N.R.
        • Hochman J.
        • Becker R.
        • et al.
        Critical pathways: a review.
        Circulation. 2000; 101: 461-465
        • Quality of care and outcomes research in CVD and stroke working group
        Measuring and improving quality of care. A report from the American Heart Association/American College of Cardiology first scientific forum on assessment of healthcare quality in cardiovascular disease and stroke.
        Stroke. 2000; 31: 1002-1012
        • Adams H.P.
        • Del Zoppo G.
        • Alberts M.J.
        • et al.
        Guidelines for the early management of adults with ischemic stroke.
        Stroke. 2007; 38: 1655-1711
      1. Stroke Prevention and Educational Awareness Diffusion (SPREAD). VII Edizione. Ictus cerebrale: linee guida italiane di prevenzione e trattamento. Available at: www.siapav.it. (accessed Sept. 18 2014).

        • Denti L.
        • Scoditti U.
        • Tonelli C.
        • et al.
        The poor outcome of ischemic stroke in very old people: a cohort study of its determinants.
        J Am Geriatr Soc. 2010; 58: 12-17
        • Van Swieten J.C.
        • Koudstaal P.J.
        • Visser M.C.
        • et al.
        Interobserver agreement for the assessment of handicap in stroke patients.
        Stroke. 1988; 19: 604-607
        • Jennet B.
        • Bond M.
        Assessment of outcome after severe brain damage: a practical scale.
        Lancet. 1975; 1: 480-484
      2. Scandinavian Stroke Study Group: Multicenter trial of hemodilution in ischaemic stroke—background and study protocol.
        Stroke. 1985; 16: 885-890
        • Bamford J.
        • Sandercock P.
        • Dennis M.
        • et al.
        Classification and natural history of clinically identifiable subtypes of cerebral infarction.
        Lancet. 1991; 337: 1521-1526
        • Adams Jr., H.P.
        • Bendixen B.H.
        • Kappelle L.J.
        Classification of subtypes of acute ischemic stroke: definition for use in a multicenter clinical trial: TOAST. Trial of Org 10 172 in Acute Stroke Treatment.
        Stroke. 1993; 24: 35-41
        • Kirchberger I.
        • Meisinger C.
        • Heier M.
        • et al.
        Patterns of multimorbidity in the aged population. Results from the KORA-Age Study.
        Plos One. 2012; 7: e30556
        • Marangoni A.
        • Rizzuto D.
        • Wang H.
        • et al.
        Patterns of chronic multimorbidity in the elderly population.
        J Am Geriatr Soc. 2009; 57: 225-230
        • Schafer I.
        • von Leitner E.C.
        • Schon G.
        • et al.
        Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions.
        Plos One. 2010; 5: e15941
        • Van den Akker M.
        • Buntinx F.
        • Metsemakers J.F.
        • et al.
        Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases.
        J Clin Epidemiol. 1998; 51: 367-375
        • Vergouwe Y.
        • Steyerberg E.W.
        • Eijkemans J.C.
        • et al.
        Substantial effective sample sizes were required for external validation studies of predictive logistic regression models.
        J Clin Epidemiol. 2005; 58: 475-483